Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / CL A
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
26,688,004
-
Shares change
-
+108,675
-
Total reported value, excl. options
-
$2,685,200,348
-
Value change
-
-$18,352,591
-
Put/Call ratio
-
249%
-
Number of buys
-
85
-
Number of sells
-
84
-
Price
-
$100.61
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2021
As of 30 Sep 2021 REATA PHARMACEUTICALS INC - CL A (RETA) had 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,688,004 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., CPMG Inc, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, FMR LLC, Duquesne Family Office LLC, and Camber Capital Management LP.
This table shows 177 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.